Emerging and reemerging respiratory viral infections up to Covid-19
Emerging and reemerging respiratory viral infections up to Covid-19
Infectious diseases remain as the significant causes of human and animal morbidity and mortality, leading to extensiveoutbreaks and epidemics. Acute respiratory viral diseases claim over 4 million deaths and cause millions of hospitalizations in developingcountries every year. Emerging viruses, especially the RNA viruses, are more pathogenic since most people have no herd immunity.The RNA viruses can adapt to the rapidly changing global and local environment due to the high error rate of their polymerases thatreplicate their genomes. Currently, coronavirus disease 2019 (COVID-19) is determined as an infectious disease caused by severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in 2019 in Wuhan. Herein we discuss emerging andreemerging respiratory viral infections till to SARS-CoV-2.
___
- 1. Dikid T, Jain SK, Sharma A, Kumar A, Narain JP. Emerging
& re-emerging infections in India: an overview. The Indian
Journal of Medical Research 2013; 138 (1): 19-31.
- 2. Johns Hopkins Medicine. Emerging Infectious Diseases.
Baltimore, MD, USA: Johns Hopkins Medicine; 2020.
- 3. World Health Organization. Influenza (Avian and other
zoonotic). Geneva, Switzerland: WHO; 2019.
- 4. Karron RA, Black RE. Determining the burden of respiratory
syncytial virus disease: The known and the unknown. Lancet
2017; 390: 917-918. doi: 10.1016/s0140-6736(17)31476-9
- 5. Zumla A, Hui DS, Al-Tawfi J, Gautret P, McCloskey B et al.
Emerging respiratory tract infections. Lancet 2014; 14: 910-
911. doi: 10.1016/ S1473-3099(14)70899-0
- 6. Park S, Park JY, Song Y, How SH, Jung K. Emerging respiratory
infections threatening public health in the Asia‐Pacific region.
A position paper of the Asian Pacific Society of Respirology.
Respirology 2019; 24: 590-597. doi: 10.1111/resp. 13558
- 7. Jaijyan DK, Liu J, Hai R, Zhu H. Emerging and reemerging
human viral diseases. Annals of Microbiology and Research
2018; 2 (1): 31-44. doi: 10.36959/958/567
- 8. Menachery VD, Yount Jr BL, Debbink K, Agnihothram S,
Gralinski LE et al. A SARS-like cluster of circulating bat
coronaviruses shows potential for human emergence. Nature
Medicine 2015; 21 (12): 1508-1513. doi: 10.1038/nm.3985
- 9. Paules C, Subbarao K. Influenza. Lancet 2017; 390 (10095):
697-708. doi: 10.1016/S0140-6736(17)30129-0
- 10. Moesker FM, L.A. Fraaij P. New, emerging, and re-emerging
respiratory viruses. In: Sunit K. Singh (editor). Viral Infection
and Global Change. 1st ed. Hoboken, NJ, USA: John Wiley and
Sons; 2014. pp. 344-375.
- 11. Asha K, Kumar B. Emerging influenza D virus threat: what we
know so far. Journal of Clinical Medicine 2019; 8 (2): 2-13. doi:
10.3390/jcm8020192
- 12. Kilbourne ED. Influenza Pandemics of the 20th Century.
Emerging Infectious Diseases 2006; 12 (1): 15-22. doi: 10.3201/
eid1201.051254
- 13. Honigsbaum M. Spanish influenza redux: revisiting the
mother of all pandemics. Lancet. 2018; 23: 391(10139): 2492-
2495. doi: 10.1016/S0140-6736(18)31360-6
- 14. Jones CY, Baranovich T, Marathe B, Danner AF, Seiler JP
et al. Risk assessment of H2N2 influenza viruses from the
Avian Reservoir. Journal of Virology 2014; 88 (2): 1175-1188.
doi: 10.1128/JVI.02526-13
- 15. Philippon DAM, Wu P, Cowling BJ, Lau EHY. Avian influenza,
human infections at the human-animal interface. The Journal
of Infectious Diseases 2020; 10: 1-31. doi: 10.1093/infdis/
jiaa105
- 16. Macneil, A, Nichol ST, Spiropoulou, CF. Hantavirus pulmonary
syndrome. Virus Research 2011; 162: 138-147. doi: 10.1016/j.
virusres.2011.09.017
- 17. Kjemtrup AM, Messenger S, Meza AM, Feiszli T, Yoshimizu
MH et al. New exposure location for Hantavirus Pulmonary
Syndrome Case, California, USA, 2018. Emerging Infectious
Diseases 2019; 25 (10): 1962-1964. doi: 10.3201/eid2510.190058
- 18. Shafagati N, Williams J. Human metapneumovirus-what
we know now. F1000Research 2018; 7: 1-11. doi: 10.12688/
f1000research.12625.1
- 19. Körner RW, Söderlund-Venermo M, Van Koningsbruggen-
Rietschel S, Kaiser R, Malecki M et al. Severe human Bocavirus
Infection, Germany. Emerging Infectious Diseases, 2011;17
(12): 2303-2305. doi: 10.3201/eid1712.110574
- 20. Burrell C, Howard C, Murphy F. Coronaviruses. Fenner and
White’s Medical Virology. 5th ed. Cambridge, MA, USA:
Academic Press; 2017. pp: 437-446.
- 21. Francis ME, King ML, Kelvin AA. Back to the future for
influenza preimmunity-looking back at influenza virus history
to infer the outcome of future infections. Viruses 2019, 11 (2):
122. doi: 10.3390/v11020122
- 22. World Health Organization. The operational response to
SARS. Geneva, Switzerland: WHO; 2019.
- 23. Cowling BJ, Park M, Fang VJ, Wu P, Leung G et al. Preliminary
epidemiological assessment of MERS-CoV outbreak in South
Korea, May to June 2015. European Surveillance Bulletin 2015;
20: 7-13. doi: 10.2807/15607917.es2015.20.25.21163
- 24. ChengLaia C, PingShih T, ChienKo W, Tang H, RenHsueh
P. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-
2) and coronavirus disease-2019 (COVID-19): The
epidemic and the challenges. International Journal of
Antimicrobial Agents 2020; 55 (3): 1-9. doi: 10.1016/j.
ijantimicag.2020.105924
- 25. Taubenberger JK, Morens DM. 1918 influenza: the mother of
all pandemics. Emerging Infectious Diseases 2006; 12 (1): 15-
22. doi: 10.1093/infdis/jiaa105
- 26. Peeri NC, Shrestha N, Rahman S, Zaki R, Tan Z et al. The
SARS, MERS and novel coronavirus (COVID-19) epidemics,
the newest and biggest global health threats: what lessons have
we learned. International Journal of Epidemiology 2020: 1-10.
doi: 10.1093/ije/dyaa033
- 27. Manman XL, Yizhao G, Liesu P, Lu MS. Molecular immune
pathogenesis and diagnosis of COVID-19. Journal of
Pharmaceutical Analysis Journal Homepage 2020: S2095-
1779(20)30204-30205. doi: org/10.1016/j.jpha.2020.03.001
- 28. Yoshikura H. Spanish flu, Asian flu, Hong Kong flu, and
seasonal influenza in Japan under social and demographic
influence: review and analysis using the two-population model.
Japanese Journal of Infectious Diseases 2014; 67:245-257. doi:
10.7883/yoken.67.245
- 29. Vassilara F, Spyridaki A, Pothitos G, Deliveliotou A,
Papadopoulos A. A rare case of human coronavirus 229E
associated with acute respiratory distress syndrome in a
healthy adult. Case Reports in Infectious Diseases 2018: 1-4.
doi: 10.1155/2018/6796839
- 30. Tawfiq JA, Zumla A, Gautret P, CGray G, SHui D et al.
Surveillance for emerging respiratory viruses. Lancet of
Infectious Diseases 2014; 14 (10): 992-1000. doi: 10.1016/
S1473-3099(14)70840-0
- 31. Taubenberger JK, Morens DM. Influenza: the once and future
pandemic. Public Health Reports 2010; 125 (3): 16-26.
- 32. Howard CR, Fletcher NF. Emerging virus diseases: can we ever
expect the unexpected? Emerging Microbes Infection 2019; 1:
1-9. doi: 10.1038/emi.2012.47
- 33. McCloskey B, Dar O, Zumla A, Heymann DL. Emerging
infectious diseases and pandemic potential: status quo and
reducing the risk of global spread. Lancet of Infectious Diseases
2014; 14: 1001-1010. doi: 10.1016/ S1473-3099 (14)70846-1